What is the coverage criteria for Medicare claims involving transitional home infusion service payments?
Is your organization ready for billing changes related to services rendered on infusion drugs?
You will need to identify which days of service and which services will be
reimbursed using the new G-Codes.
Temporary Transitional Payment for Home Infusion Therapy Services for Claims Years 2019 and 2020
Billing Medicare for Home Infusion Professional Services
Key Benefits for
Home Infusion Therapy Providers
RJ Health data makes inventory item set-up easier
Procurement/Contract Teams use RJ data to ensure claims are paid correctly
Pharmacists/Reimbursement – determine Part B/D coverage
ReimbursementCodes will crosswalk the three new G-Codes (professional services rendered on an infusion drug administration) to the corresponding J-Code. This was developed to support Home Infusion Therapy Providers with the new mandate. The Centers for Medicare & Medicaid Services (CMS) established on January 1, 2019.
THE NEW G-CODES ARE:
NDC to J-Code crosswalk validation
Conversion to NDC units
ICD10 to validate FDA and compendia approved indications
Global search of all data based on product or drug name (HCPCS/CPT and NDC)
ReimbursementCodes is the most trusted, comprehensive suite of coding (HCPCS/CPT and NDC), pricing (AWP, WAC, ASP and CMAC) and clinical crosswalks (ICD10, Min/Max, and Part B/D) to accurately support reimbursement.
Your billing practices must change and your reimbursement will be impacted.
What is the coverage criteria for new G-codes used in Medicare claims involving transitional home infusion service payments?
Which day(s) of service, and which services, can be reimbursed using the G-codes?
What are the correct service codes for three classifications of drugs?